Trial Outcomes & Findings for Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients (NCT NCT03686007)

NCT ID: NCT03686007

Last Updated: 2025-04-27

Results Overview

Mean caregiver psychological distress scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in psychological distress between the intervention and control arm over time. Score range: 0-10. Higher score means worse outcome.

Recruitment status

ACTIVE_NOT_RECRUITING

Study phase

NA

Target enrollment

380 participants

Primary outcome timeframe

Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Results posted on

2025-04-27

Participant Flow

542 participants (342 patients, 200 caregivers) were assessed for study eligibility. After 162 participants were excluded for various reasons - not meeting inclusion criteria (n= 91), declined to participate (n= 48), other/unknown reasons (n= 3), late ineligibility (n= 20), 380 participants (190 dyads - 190 patients, 190 caregivers) were randomized.

542 participants (342 patients, 200 caregivers) were assessed for study eligibility. After 162 participants were excluded for various reasons - not meeting inclusion criteria (n= 91), declined to participate (n= 48), other/unknown reasons (n= 3), late ineligibility (n= 20), 380 participants (190 dyads - 190 patients, 190 caregivers) were randomized.

Participant milestones

Participant milestones
Measure
Group I (MSM Intervention)
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Overall Study
STARTED
188
192
Overall Study
COMPLETED
156
155
Overall Study
NOT COMPLETED
32
37

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Due to missing item responses and no separate category for "Unknown" sex, the number of participants analyzed differs from the overall number of participants.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group I (MSM Intervention)
n=188 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=192 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Total
n=380 Participants
Total of all reporting groups
Age, Continuous
67.5 years
n=188 Participants
65.0 years
n=192 Participants
66.0 years
n=380 Participants
Sex: Female, Male
Female
110 Participants
n=187 Participants • Due to missing item responses and no separate category for "Unknown" sex, the number of participants analyzed differs from the overall number of participants.
116 Participants
n=192 Participants • Due to missing item responses and no separate category for "Unknown" sex, the number of participants analyzed differs from the overall number of participants.
226 Participants
n=379 Participants • Due to missing item responses and no separate category for "Unknown" sex, the number of participants analyzed differs from the overall number of participants.
Sex: Female, Male
Male
77 Participants
n=187 Participants • Due to missing item responses and no separate category for "Unknown" sex, the number of participants analyzed differs from the overall number of participants.
76 Participants
n=192 Participants • Due to missing item responses and no separate category for "Unknown" sex, the number of participants analyzed differs from the overall number of participants.
153 Participants
n=379 Participants • Due to missing item responses and no separate category for "Unknown" sex, the number of participants analyzed differs from the overall number of participants.
Ethnicity (NIH/OMB)
Hispanic or Latino
27 Participants
n=188 Participants
21 Participants
n=192 Participants
48 Participants
n=380 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
153 Participants
n=188 Participants
166 Participants
n=192 Participants
319 Participants
n=380 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
8 Participants
n=188 Participants
5 Participants
n=192 Participants
13 Participants
n=380 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=188 Participants
0 Participants
n=192 Participants
1 Participants
n=380 Participants
Race (NIH/OMB)
Asian
42 Participants
n=188 Participants
43 Participants
n=192 Participants
85 Participants
n=380 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=188 Participants
1 Participants
n=192 Participants
2 Participants
n=380 Participants
Race (NIH/OMB)
Black or African American
4 Participants
n=188 Participants
8 Participants
n=192 Participants
12 Participants
n=380 Participants
Race (NIH/OMB)
White
126 Participants
n=188 Participants
118 Participants
n=192 Participants
244 Participants
n=380 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=188 Participants
6 Participants
n=192 Participants
7 Participants
n=380 Participants
Race (NIH/OMB)
Unknown or Not Reported
13 Participants
n=188 Participants
16 Participants
n=192 Participants
29 Participants
n=380 Participants
Region of Enrollment
United States
188 participants
n=188 Participants
192 participants
n=192 Participants
380 participants
n=380 Participants

PRIMARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

Mean caregiver psychological distress scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in psychological distress between the intervention and control arm over time. Score range: 0-10. Higher score means worse outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=92 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=96 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)
Baseline
3.92 score on a scale
Interval 3.38 to 4.47
4.19 score on a scale
Interval 3.65 to 4.72
Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)
1 month post-discharge
3.38 score on a scale
Interval 2.79 to 3.98
3.74 score on a scale
Interval 3.12 to 4.36
Change in Family Caregiver Psychological Distress (as Measured by the Distress Thermometer)
3 months post-discharge
3.22 score on a scale
Interval 2.62 to 3.82
4.14 score on a scale
Interval 3.54 to 4.74

PRIMARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

Mean caregiver burden scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in burden between the intervention and control arm over time. The model included treatment arm, time, and the interaction between treatment arm and time as effects. Total burden score is calculated by summing items from 3 subscales: objective burden, subjective burden \& demand burden. Score range: 14-70. Higher score means worse outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=93 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=95 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)
Baseline
44.68 score on a scale
Interval 43.01 to 46.35
44.56 score on a scale
Interval 42.91 to 46.21
Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)
1 month post-discharge
42.19 score on a scale
Interval 40.36 to 44.02
44.73 score on a scale
Interval 42.83 to 46.63
Change in Caregiving Burden (as Measured by the Montgomery Borgatta Caregiver Burden Scale)
3 months post-discharge
40.45 score on a scale
Interval 38.63 to 42.27
42.00 score on a scale
Interval 40.18 to 43.82

PRIMARY outcome

Timeframe: Outcomes are measured before surgery (baseline), 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

Mean caregiver preparedness scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in preparedness between the intervention and control arm over time. Score range: 0-4. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=93 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=95 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)
Baseline
2.55 score on a scale
Interval 2.38 to 2.72
2.60 score on a scale
Interval 2.44 to 2.77
Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)
1 month post-discharge
2.98 score on a scale
Interval 2.8 to 3.16
2.88 score on a scale
Interval 2.7 to 3.07
Change in Preparedness for Caregiving (as Measured by the Preparedness for Caregiving Scale)
3 months post-discharge
2.94 score on a scale
Interval 2.76 to 3.12
2.78 score on a scale
Interval 2.6 to 2.96

PRIMARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

Mean caregiver QoL scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in QoL between the intervention and control arm over time. Total QoL score is calculated by summing items from 3 subscales: physical well-being, psychological well-being, social concerns \& spiritual well-being. Score range: 0-40. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=93 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=94 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)
1 month post-discharge
27.69 score on a scale
Interval 26.45 to 28.94
26.67 score on a scale
Interval 25.4 to 27.94
Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)
3 months post-discharge
27.51 score on a scale
Interval 26.27 to 28.76
26.43 score on a scale
Interval 25.2 to 27.67
Change in Family Caregiver Quality of Life (as Measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)
Baseline
27.04 score on a scale
Interval 25.85 to 28.22
26.83 score on a scale
Interval 25.65 to 28.01

PRIMARY outcome

Timeframe: Outcomes are measured at discharge, 1 month, and 3 months post-discharge.

Population: Due to attrition in the study, the number of family caregivers assessed at discharge differs from the number of family caregivers analyzed during follow-up.

Differences in the number of caregivers who saw a support services specialist were compared between both groups using Chi-squared and Fisher's exact test.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=90 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=94 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)
3 months post-discharge
0 Participants
2 Participants
Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)
Discharge
8 Participants
5 Participants
Number of Participants Who Used Family Caregiver Resource (as Measured by the Family Caregiver Healthcare Use Inventory)
1 month post-discharge
2 Participants
0 Participants

PRIMARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

Mean patient psychological distress scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in psychological distress between the intervention and control arm over time. Score range: 0-10. Higher score means worse outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=94 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=96 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Patient Psychological Distress (as Measured by the Distress Thermometer)
Baseline
4.23 score on a scale
Interval 3.6 to 4.8
4.39 score on a scale
Interval 3.8 to 5.0
Change in Patient Psychological Distress (as Measured by the Distress Thermometer)
1 month post-discharge
3.42 score on a scale
Interval 2.8 to 4.1
3.55 score on a scale
Interval 2.9 to 4.2
Change in Patient Psychological Distress (as Measured by the Distress Thermometer)
3 months post-discharge
3.25 score on a scale
Interval 2.6 to 3.9
3.76 score on a scale
Interval 3.1 to 4.4

PRIMARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

Mean patient QoL scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in QoL between the intervention and control arm over time. Total FACT-L score is calculated by summing items from 5 subscales: physical well-being, social/family well-being, emotional well-being, functional well-being \& lung cancer subscale. Score range: 0-136. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=93 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=94 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)
Baseline
106.09 score on a scale
Interval 102.2 to 109.9
104.27 score on a scale
Interval 100.4 to 108.1
Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)
1 month post-discharge
103.97 score on a scale
Interval 99.8 to 108.1
99.17 score on a scale
Interval 94.9 to 103.5
Change in Patient Quality of Life (as Measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)
3 months post-discharge
103.54 score on a scale
Interval 99.5 to 107.6
101.04 score on a scale
Interval 96.9 to 105.2

PRIMARY outcome

Timeframe: Outcomes are measured at 1 month, and 3 months post-discharge.

Population: Due to attrition in the study, the number of patients assessed differed during follow-up timepoints.

Differences in the number of patients who were readmitted to the hospital for an overnight stay were compared between both groups using Chi-squared and Fisher's exact test.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=90 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=90 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)
1 month post-discharge
4 Participants
2 Participants
Number of Participants Who Used Patient Healthcare Resource Use (Home Health Nursing Care, Urgent/ER Visits, Hospital Readmissions)
3 months post-discharge
7 Participants
8 Participants

SECONDARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

Mean caregiver self-efficacy scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in self-efficacy between the intervention and control arm over time. Score range: 1-4. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=92 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=93 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)
Baseline
3.33 score on a scale
Interval 3.22 to 3.44
3.33 score on a scale
Interval 3.22 to 3.44
Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)
1 month post-discharge
3.47 score on a scale
Interval 3.35 to 3.59
3.38 score on a scale
Interval 3.25 to 3.5
Change in Family Caregiver Self-efficacy (as Measured by the Self-Efficacy Scale)
3 months post-discharge
3.52 score on a scale
Interval 3.41 to 3.64
3.40 score on a scale
Interval 3.28 to 3.52

SECONDARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

Mean patient self-efficacy scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in self-efficacy between the intervention and control arm over time. Score range: 1-4. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=94 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=94 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)
Baseline
3.60 score on a scale
Interval 3.5 to 3.7
3.51 score on a scale
Interval 3.4 to 3.6
Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)
1 month post-discharge
3.60 score on a scale
Interval 3.5 to 3.7
3.52 score on a scale
Interval 3.4 to 3.6
Change in Patient Self-efficacy (as Measured by the Self-Efficacy Scale)
3 months post-discharge
3.56 score on a scale
Interval 3.5 to 3.7
3.55 score on a scale
Interval 3.4 to 3.7

SECONDARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

Mean caregiver activation scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in activation between the intervention and control arm over time. Score range: 10-60. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=93 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=93 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)
Baseline
46.33 score on a scale
Interval 44.3 to 48.37
47.30 score on a scale
Interval 45.27 to 49.33
Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)
3 months post-discharge
47.79 score on a scale
Interval 45.62 to 49.96
48.37 score on a scale
Interval 46.22 to 50.53
Change in Family Caregiver Activation (as Measured by the FCG Activation in Transitions Tool)
1 month post-discharge
48.50 score on a scale
Interval 46.34 to 50.67
48.76 score on a scale
Interval 46.54 to 50.99

SECONDARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge. Absolute values are reported at each timeframe.

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

Mean patient activation scores from baseline to 3 months post-discharge were calculated. A linear mixed-effects model was used to assess differences in activation between the intervention and control arm over time. Score range: 0-100. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=94 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=95 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Patient Activation (as Measured by the Patient Activation Measure)
Baseline
73.30 score on a scale
Interval 69.7 to 76.9
71.51 score on a scale
Interval 67.9 to 75.1
Change in Patient Activation (as Measured by the Patient Activation Measure)
1 month post-discharge
75.41 score on a scale
Interval 71.6 to 79.3
71.00 score on a scale
Interval 67.0 to 75.0
Change in Patient Activation (as Measured by the Patient Activation Measure)
3 months post-discharge
74.47 score on a scale
Interval 70.7 to 78.3
72.38 score on a scale
Interval 68.5 to 76.3

SECONDARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge

Population: Due to attrition in the study, the number of family caregivers assessed at baseline differs from the number of family caregivers analyzed during follow-up.

Mean family caregiver knowledge scores from baseline to 3 months post-discharge were calculated. T-tests were used to assess differences in knowledge between the intervention and control arm at different timepoints. Score range: 0-10. Mean: 8.24 with a standard deviation of 1.19. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=94 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=96 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)
Baseline
8.00 T-score
Standard Deviation 1.16
7.64 T-score
Standard Deviation 1.42
Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)
1 month post-discharge
8.76 T-score
Standard Deviation 0.85
8.45 T-score
Standard Deviation 0.91
Change in Family Caregiver Knowledge (as Measured by the Surgery-Related Knowledge Tool)
3 months post-discharge
8.69 T-score
Standard Deviation 0.91
8.15 T-score
Standard Deviation 1.26

SECONDARY outcome

Timeframe: Outcomes are measured at baseline, 1 month, and 3 months post-discharge

Population: Due to attrition in the study, the number of patients assessed at baseline differs from the number of patients analyzed during follow-up.

Mean patient knowledge scores from baseline to 3 months post-discharge were calculated. T-tests were used to assess differences in knowledge between the intervention and control arm at different timepoints. Score range: 0-10. Mean: 8.42 with a standard deviation of 1.16. Higher score means better outcome.

Outcome measures

Outcome measures
Measure
Group I (MSM Intervention)
n=94 Participants
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive MSM intervention handbook Informational Intervention: Receive MSM intervention research nurse coaching Media Intervention: View the MSM intervention videos Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Attention Control)
n=96 Participants
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge. Informational Intervention: Receive ASCO print materials Informational Intervention: Receive CRA assistance Media Intervention: View ASCO Cancer.net videos
Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)
Baseline
7.98 T-score
Standard Deviation 1.25
7.98 T-score
Standard Deviation 1.03
Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)
1 month post-discharge
9.00 T-score
Standard Deviation 1.18
8.48 T-score
Standard Deviation 1.11
Change in Patient Knowledge (as Measured by the Surgery-Related Knowledge Tool)
3 months post-discharge
8.82 T-score
Standard Deviation 1.00
8.50 T-score
Standard Deviation 0.90

Adverse Events

Group I (MSM Intervention)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Group II (Attention Control)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Virginia Sun

City of Hope Medical Center

Phone: 626-359-8111

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place